SYH2095 for Advanced Malignant Tumors: Phase I Study

NCT07692776 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SYH2095

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Collaborators

[object Object]